SEC Filings

SEC Filings

Filing date	Description	Form	View
Jun 23, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-22-010229.pdf 0001558370-22-010229.rtf 0001558370-22-010229.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 06, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-22-000080.pdf 0001235802-22-000080.rtf 0001235802-22-000080.xls
Jul 06, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-22-000081.pdf 0001235802-22-000081.rtf 0001235802-22-000081.xls
Jul 21, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-22-081580.pdf 0001104659-22-081580.rtf 0001104659-22-081580.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 25, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-22-082394.pdf 0001104659-22-082394.rtf 0001104659-22-082394.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 02, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-22-085182.pdf 0001104659-22-085182.rtf 0001104659-22-085182.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 11, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-22-000091.pdf 0001235802-22-000091.rtf 0001235802-22-000091.xls
Aug 11, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-22-000092.pdf 0001235802-22-000092.rtf 0001235802-22-000092.xls
Aug 16, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-22-013698.pdf 0001558370-22-013698.rtf 0001558370-22-013698.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 16, 2022	Notification that form type 10-Q will be submitted late	NT 10-Q	View HTML 0001558370-22-013691.pdf 0001558370-22-013691.rtf 0001558370-22-013691.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE